Filter Results :

Your search for therapies returned 65 reports

Sort by


Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryBiotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pri...

$ 250.00

Read More

BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryBioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is design...

$ 250.00

Read More

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a 'Watchful Waiting' and Resistance Population

01 Feb 2017  |  Published by:  MP Advisors
This report details current unmet need, changing regulatory requirement, reimbursement challenges & market dynamics of Prostate Cancer drugs.  Report mention pipeline Antiandrogens, late stage prostate cancer pipeline drugs/new Mechanism of action & major companies developing Prostate c...

$ 4,500.00

Read More

Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile

25 Jan 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company’s clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system designe...

$ 250.00

Read More

Breakthrough Therapies: Market Dynamics and Investment Opportunities

24 Jan 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.Report Includes-An overview of the global markets for breakthrough therapies, their dynamics, and investment ...

$ 6,650.00

Read More

Vital Therapies Inc (VTL) - Financial and Strategic SWOT Analysis Review

13 Jan 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company’s clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system designe...

$ 300.00

Read More

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

02 Jan 2017  |  Published by:  GBI Research
SummaryInfluenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the el...

$ 4,995.00

Read More

COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

01 Jan 2017  |  Published by:  GBI Research
SummaryChronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of ...

$ 4,995.00

Read More

Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Dec 2016  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company’s clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system designe...

$ 250.00

Read More

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

01 Dec 2016  |  Published by:  GBI Research
SummaryCancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause a cell to become malignant. A number of cellular processes must be deregulated to allow cells to proliferate uncontrollably while eva...

$ 4,995.00

Read More

Tissue Therapies Ltd (FTT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Nov 2016  |  Published by:  GlobalData
SummaryTissue Therapies Ltd (FTL), formerly Tissue Therapies Ltd, which focuses on the development and commercialization of advanced wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic c...

$ 250.00

Read More

Biotie Therapies AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Nov 2016  |  Published by:  GlobalData
SummaryBiotie Therapies AG (Biotie) is a specialized drug development company. It focuses on the development of products for neurodegenerative and psychiatric disorders such as Parkinson's disease, primary sclerosing cholangitis and others. The company's lead product Selincro, is an orally administe...

$ 250.00

Read More

Advanced Catheter Therapies Inc - Medical Equipment - Deals and Alliances Profile

04 Nov 2016  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies Inc (ACT) is a medical device company that offers novel catheter technologies targeting vascular disease such as inflammation, thrombosis, occlusions and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It offe...

$ 250.00

Read More

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

01 Nov 2016  |  Published by:  GBI Research
SummaryHemophilia is a rare disease affecting more than 400,000 people worldwide. Hemophilia A is four times as common as hemophilia B, and more than half of patients with hemophilia A have a severe form of hemophilia. Males have a much higher chance of developing hemophilia because they only receiv...

$ 4,995.00

Read More

Global Allergy Immunotherapies Market Research Report 2016

16 Sep 2016  |  Published by:  9Dimen Research
2016 Global Allergy Immunotherapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Allergy Immunotherapies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Ja...

$ 2,850.00
$ 2,565.00
( Save 10% )

Read More
Total 65 records.